EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Stem cell-derived extracellular vesicles as senotherapeutics

Ekaterina Rudnitsky, Alex Braiman, Marina Wolfson, Khachik K Muradian, Vera Gorbunova, Gadi Turgeman, Vadim E Fraifeld

Ageing Research Reviews · 2024

DOI: 10.1016/j.arr.2024.102391 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2024. Verfasst von Ekaterina Rudnitsky und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Center for Multidisciplinary Research on Aging, Ben…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Cellular Senescence, Senotherapeutics. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 109 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence (CS) is recognized as one of the hallmarks of aging, and an important player in a variety of age-related pathologies. Accumulation of senescent cells can promote a pro-inflammatory and pro-cancerogenic microenvironment. Among potential senotherapeutics are extracellular vesicles (EVs) (40-1000 nm), including exosomes (40-150 nm), that play an important role in cell-cell communications. Here, we review the most recent studies on the impact of EVs derived from stem cells (MSCs, ESCs, iPSCs) as well as non-stem cells of various types on CS and discuss potential mechanisms responsible for the senotherapeutic effects of EVs. The analysis revealed that (i) EVs derived from stem cells, pluripotent (ESCs, iPSCs) or multipotent (MSCs of various origin), can mitigate the cellular senescence phenotype both in vitro and in vivo; (ii) this effect is presumably senomorphic; (iii) EVs display cross-species activity, without apparent immunogenic responses. In summary, stem cell-derived EVs appear to be promising senotherapeutics, with a feasible application in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesCellular SenescenceSenotherapeuticsHumansAnimalsStem CellsAging

Stichwörter der Autor:innen

Cellular senescenceESCExtracellular vesiclesMSCiPSC

Substanzen

Senotherapeutics

Autor:innen und Institutionen

  • The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Center for Multidisciplinary Research on Aging, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
  • Department of Biology of Aging and Experimental Life Span Extension, State Institute of Gerontology of National Academy of Medical Sciences of Ukraine, Kiev 4114, Ukraine.
  • Department of Biology, Rochester Aging Research Center, University of Rochester, Rochester, NY 14627, USA.
  • Department of Molecular Biology, Faculty of Natural Sciences and Medical School, Ariel University, Ariel 40700, Israel. Electronic address: gadit@ariel.ac.il.
  • The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Center for Multidisciplinary Research on Aging, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Electroni…

Zitieren

APA

Rudnitsky, E., Braiman, A., Wolfson, M., Muradian, K. K., Gorbunova, V., Turgeman, G., & Fraifeld, V. E. (2024). Stem cell-derived extracellular vesicles as senotherapeutics. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2024.102391

Vancouver

Rudnitsky E, Braiman A, Wolfson M, Muradian KK, Gorbunova V, Turgeman G, et al. Stem cell-derived extracellular vesicles as senotherapeutics. Ageing Research Reviews. 2024. doi:10.1016/j.arr.2024.102391

BibTeX
@article{Rudnitsky2024,
  author = {Rudnitsky, Ekaterina and Braiman, Alex and Wolfson, Marina and Muradian, Khachik K and Gorbunova, Vera and Turgeman, Gadi and Fraifeld, Vadim E},
  title = {Stem cell-derived extracellular vesicles as senotherapeutics},
  journal = {Ageing Research Reviews},
  year = {2024},
  doi = {10.1016/j.arr.2024.102391}
}
Kostenlos starten →